Q&A: Targeting APRIL in IgA Nephropathy Shows Promise
Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of targeting APRIL. The post Q&A: Targeting APRIL in IgA Nephropathy Shows Promise first...
Read more